Lumexa Imaging Holdings, Inc. (LMRI) Fair Value 2026

LMRI · Services-Medical Laboratories ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

1.9 /10

32 fundamental signals · 10 models active

Value Trap Risk

— (—/100)

Quick Summary — As of 2026-07-17, Lumexa Imaging Holdings, Inc. (LMRI) trades at $11.20, approximately 349% above CirclFi’s Bayesian DCF fair value of $2.49. QOC: 1.9/10. 10/13 models active.

Key Facts

Ticker
LMRI
Price
$11.20
Quality Score
1.9/10
Value Trap Risk
—/100
Models Active
10/13
Last Updated
Strength: First Chicago suggests +42.1% upside with 7% confidence
Risk: Below-average Quality Score of 1.9/10 signals weak fundamentals

Is Lumexa Imaging Holdings, Inc. (LMRI) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Lumexa Imaging Holdings, Inc. (LMRI) appears overvalued as of : the median of 10 independent fair value estimates is $9.05, 19.2% below the current price of $11.20. Estimates range from $2.45 to $19.10. LMRI scores 1.9/10 on fundamental quality and —/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Lumexa Imaging Holdings, Inc. Stock in 2026? →

Valuation Matrix

10 Intrinsic Value Models vs. Current Price ($11.20)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $2.49 -77.7%
CUCE Ensemble
Low Conviction
 $6.73 -39.9%
First Chicago
Low Conviction
 $15.91 +42.1%
RCMH-DCF
Low Conviction
 $2.45 -78.2%

Unlock the Full Matrix

Access 6 additional models including ML-RIV, Dynamic NAV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is Lumexa Imaging Holdings, Inc. (LMRI) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Lumexa Imaging Holdings, Inc.'s intrinsic value is estimated at a composite fair value of $9.85. Trading at $11.20, the stock is approaching fair value or slight overvaluation (implied return of -12.1%), as 6 of 10 models suggest limited further upside. Model dispersion is worth noting: Sentiment SOTP targets $19.10 (+70.5%), versus RCMH-DCF at $2.45 (-78.2%). This +148.7% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About LMRI?

10 of 13 models are currently active for LMRI. Of these, 4 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates LMRI's intrinsic value at $2.49, implying -77.7% downside from the current price. See which stocks rank higher →

How Does LMRI Rank in Services-Medical Laboratories?

Among 24 Services-Medical Laboratories stocks, LMRI ranks #24 by Quality of Company score. CirclFi's QOC score of 1.9/10 evaluates 32 fundamental signals. A score of 1.9 signals below-average fundamentals.

Lumexa Imaging Holdings, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is LMRI a Value Trap?

The Value Trap algorithm is not active for LMRI. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Lumexa Imaging Holdings, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Lumexa Imaging Holdings, Inc. earns a quality score of 1.9/10. This concerning rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +148.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every LMRI valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across LMRI's 10 active models, average confidence is 4%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Lumexa Imaging Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Medical Laboratories Stocks Should You Also Analyze?

8 related Services-Medical Laboratories stocks with 13-model coverage

CSTLCastle Biosciences, Inc.QOC 9.2VCYTVeracyte, Inc.QOC 8.8DGXQuest Diagnostics IncorporatedQOC 8.3CDNACareDx, Inc.QOC 7.8FLGTFulgent Genetics, Inc.QOC 7.7LHLabcorp Holdings Inc.QOC 7.6RDNTRadNet, Inc.QOC 7.1XGNExagen Inc.QOC 7.0

Read investment analysis: CSTL · VCYT · DGX · CDNA · FLGT

Frequently Asked Questions About Lumexa Imaging Holdings, Inc.

What is Lumexa Imaging Holdings, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Lumexa Imaging Holdings, Inc. (LMRI) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $2.49. The Quality of Company score is 1.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is LMRI overvalued or undervalued right now?

At $11.20, 4 of 10 active models suggest LMRI may be undervalued, while 6 indicate potential overvaluation. The median of all 10 fair value estimates is $9.05, 19.2% below the current price of $11.20 — a consensus view that LMRI is overvalued. The assessment depends on which methodology best fits Lumexa Imaging Holdings, Inc.'s business model in Services-Medical Laboratories.

What does a Quality of Company score of 1.9 mean for LMRI?

Lumexa Imaging Holdings, Inc.'s QOC of 1.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on LMRI?

CirclFi analyzes LMRI with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Is LMRI a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for LMRI at this time. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Lumexa Imaging Holdings, Inc. (LMRI) has a median fair value of $9.05 — 19.2% below the current price of $11.20 — as of 2026-07-17.” Source: circlfi.com/stock/LMRI/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on LMRI.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access